🇺🇸 FDA
Patent

US 8569320

Topical composition for the treatment of actinic keratosis

granted A61KA61K31/196A61K31/513

Quick answer

US patent 8569320 (Topical composition for the treatment of actinic keratosis) held by Almirall Hermal GmbH expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Almirall Hermal GmbH
Grant date
Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/196, A61K31/513, A61K31/60, A61K45/06